Banque Pictet & Cie Sa Edwards Lifesciences Corp Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

A detailed history of Banque Pictet & Cie Sa transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 76,117 shares of EW stock, worth $5.64 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

76,117

Holding current value

$5.64 Million

% of portfolio

0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$59.7 - $93.78 $4.54 Million - $7.14 Million	76,117 New	76,117 $5.02 Million
Q3 2023 Nov 02, 2023	SELL	$69.28 - $93.38 $171,814 - $231,582	-2,480 Reduced 14.49%	14,639 $1.01 Million
Q2 2023 Aug 04, 2023	SELL	$81.41 - $94.33 $7.24 Million - $8.39 Million	-88,916 Reduced 83.86%	17,119 $1.61 Million
Q1 2023 May 01, 2023	BUY	$74.26 - $84.51 $177,555 - $202,063	2,391 Added 2.31%	106,035 $8.77 Million
Q4 2022 Feb 06, 2023	SELL	$68.3 - $87.44 $1.19 Million - $1.53 Million	-17,462 Reduced 14.42%	103,644 $0
Q3 2022 Nov 10, 2022	SELL	$82.37 - $107.29 $1.12 Million - $1.46 Million	-13,593 Reduced 10.09%	121,106 $10 Billion
Q2 2022 Aug 08, 2022	SELL	$86.5 - $128.27 $870,709 - $1.29 Million	-10,066 Reduced 6.95%	134,699 $12.8 Million
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $1.05 Million - $1.32 Million	-10,254 Reduced 6.61%	144,765 $17 Million
Q4 2021 Feb 02, 2022	BUY	$106.37 - $130.68 $14.5 Million - $17.8 Million	136,116 Added 720.08%	155,019 $20.1 Million
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $148,499 - $177,128	-1,443 Reduced 7.09%	18,903 $2.14 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $70,257 - $87,788	838 Added 4.3%	20,346 $2.11 Million
Q1 2021 May 11, 2021	BUY	$78.68 - $90.67 $1.14 Million - $1.31 Million	14,438 Added 284.77%	19,508 $1.63 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $58,283 - $74,169	-813 Reduced 13.82%	5,070 $463,000
Q3 2020 Nov 10, 2020	BUY	$67.19 - $87.44 $90,101 - $117,257	1,341 Added 29.52%	5,883 $470,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $178,258 - $238,391	3,098 Added 214.54%	4,542 $314,000
Q1 2020 Apr 30, 2020	SELL	$52.41 - $81.0 $73,740 - $113,967	-1,407 Reduced 49.35%	1,444 $272,000
Q1 2019 May 02, 2019	SELL	$47.89 - $64.05 $36,635 - $48,998	-765 Reduced 21.16%	2,851 $545,000
Q4 2018 Jan 31, 2019	SELL	$46.41 - $56.94 $20,884 - $25,623	-450 Reduced 11.07%	3,616 $554,000
Q3 2018 Nov 07, 2018	SELL	$45.7 - $58.03 $17,137 - $21,761	-375 Reduced 8.44%	4,066 $708,000
Q1 2018 May 09, 2018	BUY	$37.19 - $47.45 $88,549 - $112,978	2,381 Added 115.58%	4,441 $620,000
Q4 2017 Feb 09, 2018	SELL	$33.79 - $39.39 $848,129 - $988,689	-25,100 Reduced 92.42%	2,060 $232,000
Q2 2017 Aug 09, 2017	BUY	N/A	27,160	27,160 $3.21 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account

Banque Pictet & Cie Sa Edwards Lifesciences Corp Transaction History